RNAi Pesticides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Insect Pest Control, Weed Management, Disease Management, Resistance Management), By Crop Type (Agricultural Application, Non-Agricultural Application), By Product (Tropical RNAi Pesticide, Seed Embedded RANi, Transgenic RNAi, Others), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 1.72 Billion
CAGR (2026-2031)	9.96%
Fastest Growing Segment	Agricultural Application
Largest Market	North America
Market Size (2031)	USD 3.04 Billion

Market Overview

The Global RNAi Pesticides Market will grow from USD 1.72 Billion in 2025 to USD 3.04 Billion by 2031 at a 9.96% CAGR. RNAi pesticides utilize double-stranded RNA sequences to trigger gene silencing in specific pests, inhibiting essential protein synthesis and causing mortality while sparing non-target organisms. The market is primarily driven by the urgent global demand for residue-free agricultural produce and the increasing resistance of pests to conventional chemical synthetics. Furthermore, supportive regulatory frameworks accelerating the approval of biological crop protection agents provide a robust foundation for industry expansion distinct from temporary adoption trends.

Despite this potential, the sector faces a significant challenge regarding the high cost of double-stranded RNA production and its rapid degradation in environmental conditions which complicates field application. Commercial confidence in the broader sector remains strong as evidenced by recent industry data. According to the International Biocontrol Manufacturers Association, in 2024, the European biocontrol market reached a value of 1.6 billion euros following a doubling of the sector size since 2016. This substantial growth in the parent industry underscores the increasing commercial viability of biological alternatives like RNAi.

Key Market Drivers

Escalating pest resistance to conventional chemical pesticides is the primary catalyst propelling the Global RNAi Pesticides Market. As target organisms develop immunity to existing synthetic compounds, the agricultural sector faces diminishing yield security and spiraling control costs, creating an urgent imperative for novel modes of action like RNA interference that can silence specific genes. This economic pressure is severe and underscores the financial necessity for effective biological alternatives. According to Potato Business, January 2024, the growing issue of chemical pesticide resistance is predicted to cost the United States agricultural sector at least USD 10 billion annually. Consequently, growers are increasingly seeking alternative solutions that can overcome these resistance mechanisms while preserving environmental integrity.

Simultaneously, technological breakthroughs in RNAi delivery and formulation stability are effectively dismantling historical barriers related to field persistence and production costs. Recent innovations have enabled the encapsulation of double-stranded RNA in robust carriers, ensuring efficacy in diverse environmental conditions and securing regulatory validation. For instance, according to GreenLight Biosciences, January 2024, field trials for its newly registered Calantha bioinsecticide demonstrated effective pest control with application rates as low as 4 grams per acre. Such precision demonstrates the sector's progress in creating stable, field-ready products, which is further attracting significant capital. Illustrating this investment momentum, according to AgroSpheres, in September 2024, the company secured $37 million in Series B funding to scale its proprietary biomanufacturing and delivery platform.

Download Free Sample Report

Key Market Challenges

The high cost of double-stranded RNA (dsRNA) production combined with its rapid environmental degradation constitutes a severe impediment to the commercial scalability of the Global RNAi Pesticides Market. Manufacturing these specialized RNA sequences involves complex fermentation or chemical synthesis processes that remain significantly more expensive than conventional agrochemicals, making the final product economically unfeasible for many low-margin staple crops. This price disparity limits the technology's competitiveness, forcing manufacturers to restrict their focus to high-value niche markets rather than broad-acre agriculture.

Furthermore, the inherent instability of naked dsRNA, which breaks down quickly under UV light and rain, necessitates the development of sophisticated encapsulation technologies. This requirement adds layers of technical complexity and developmental expense, further delaying market entry. According to CropLife International, in 2024, the average cost to discover, develop, and register a new crop protection active ingredient reached $301 million, with a development timeline extending over 12 years. These immense capital and time requirements create high barriers to entry, discouraging investment from smaller biotech firms and slowing the overall rate of product commercialization within the RNAi sector.

Key Market Trends

The Commercialization of Sprayable and Topical RNAi Biopesticides is rapidly transitioning from experimental field trials to active market penetration, supported by substantial late-stage capital injections aimed at scaling manufacturing capabilities. As the technology matures, companies are securing the necessary financial resources to expand production capacities for foliar-applied solutions that offer residue-free pest control. Illustrating this push toward mass-market availability, according to GreenLight Biosciences, March 2025, the company closed a $25 million Series C funding round led by Just Climate to support the commercial rollout of its registered RNA-based crop protection products. This influx of capital highlights the industry's shift from discovery to commercial execution, enabling the broad distribution of shelf-stable, sprayable RNA formulations that integrate seamlessly into existing farming operations without requiring transgenic seeds.

Strategic Collaborations Between Agrochemical Giants and Biotech Startups are simultaneously reshaping the competitive landscape by combining the specialized gene-silencing platforms of emerging firms with the global distribution networks of established incumbents. These partnerships allow large multinationals to rapidly integrate cutting-edge gene-editing and RNAi traits into their portfolios while providing smaller innovators access to vast international markets. For instance, according to Syngenta Vegetable Seeds, May 2025, the company entered a collaboration with Tropic to deploy the Gene Editing induced Gene Silencing (GEiGS) technology across its global footprint, which spans more than 90 countries. This trend underscores a symbiotic business model where the immense commercial reach of legacy agrochemical players is leveraged to accelerate the deployment of precise, disease-resistant biological traits developed by specialized biotech pioneers.

Segmental Insights

The Agricultural Application segment stands out as the fastest-growing category in the Global RNAi Pesticides Market, driven by the urgent need for sustainable resistance management. As insect pests increasingly survive traditional chemical treatments, RNAi technology provides a specific gene-silencing mechanism that eliminates targets without harming beneficial organisms. This segment's expansion is substantiated by the U.S. Environmental Protection Agency, which recently granted registration to the first foliar RNAi biopesticide, Calantha. These regulatory advancements validate the technology's safety and efficacy, prompting widespread adoption among commercial growers seeking environmentally responsible crop protection strategies.

Regional Insights

North America holds the leading position in the Global RNAi Pesticides Market, primarily due to established regulatory clarity and robust research infrastructure. The United States Environmental Protection Agency has developed specific frameworks for assessing RNA-based agricultural products, which accelerates commercialization and builds industry confidence. Furthermore, the region benefits from a high concentration of agricultural biotechnology companies investing in sustainable crop protection methods. The widespread adoption of integrated pest management practices across the United States and Canada creates a strong demand for these targeted biological solutions, ensuring continued regional dominance.

Recent Developments

• In September 2025, GreenLight Biosciences launched Norroa, a groundbreaking RNA-based solution designed to control Varroa mites, a devastating pest affecting honeybee populations globally. This product launch represented a significant expansion of the company's RNAi portfolio beyond crop protection into animal health. Norroa utilizes a targeted RNA mechanism to suppress the mites without harming the bees, addressing a critical need for beekeepers who have struggled with mite resistance to traditional chemical treatments. The launch followed successful field trials and regulatory assessments demonstrating the product's efficacy and safety profile.
• In May 2025, Syngenta Vegetable Seeds and Tropic engaged in a strategic collaboration to develop disease-resistant vegetable varieties using advanced breeding technologies. The partnership focused on leveraging Tropic's proprietary Gene Editing induced Gene Silencing (GEiGS) technology, which redirects the silencing activity of a plant's own non-coding genes to target pathogens. This approach introduced novel RNA interference (RNAi) activity with high specificity, allowing for the development of crops that can withstand pressure from viruses and fungal diseases, thereby reducing the reliance on chemical treatments and improving yield stability for growers.
• In May 2024, FMC Corporation announced a strategic research collaboration with AgroSpheres, a biotechnology company specializing in agriculture. The partnership aimed to accelerate the discovery and development of innovative bioinsecticides based on RNA interference (RNAi) technology. By leveraging AgroSpheres' proprietary manufacturing and encapsulation platform, which stabilizes RNA molecules for effective delivery, and combining it with FMC's high-throughput testing and commercial capabilities, the companies sought to overcome stability challenges associated with RNAi products and bring sustainable crop protection solutions to the market more efficiently.
• In January 2024, GreenLight Biosciences received approval from the United States Environmental Protection Agency (EPA) for Calantha, a novel bioinsecticide designed to control the Colorado potato beetle. This regulatory milestone marked the registration of the first foliar-applied product with an RNA interference (RNAi) ingredient under the Federal Insecticide, Fungicide, and Rodenticide Act. The product utilizes double-stranded RNA (dsRNA) to specifically target and silence a gene essential for the beetle's survival, offering a new mode of action for farmers facing pesticide resistance issues while degrading rapidly in the environment to minimize impact on non-target organisms.

Key Market Players

• Bayer CropScience
• Syngenta
• Corteva Agriscience
• Evogene
• RNAissance
• Benson Hill
• Vestaron
• AgBiome
• DSV Biotech
• NRC

By Application	By Crop Type	By Product	By Region
Insect Pest Control Weed Management Disease Management Resistance Management	Agricultural Application Non-Agricultural Application	Tropical RNAi Pesticide Seed Embedded RANi Transgenic RNAi Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global RNAi Pesticides Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• RNAi Pesticides Market, By Application:

• Insect Pest Control
• Weed Management
• Disease Management
• Resistance Management

• RNAi Pesticides Market, By Crop Type:

• Agricultural Application
• Non-Agricultural Application

• RNAi Pesticides Market, By Product:

• Tropical RNAi Pesticide
• Seed Embedded RANi
• Transgenic RNAi
• Others

• RNAi Pesticides Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE